[{"_id":"551f898231cae9239deb17be","会社名":"(株)カワチ薬品【2664】","証券コード":"2664","決算期":"2014年3月期","会計方式":"日本方式","決算発表日":"2014年4月30日","決算月数":"12か月","売上高":"242,684百万円","営業利益":"7,180百万円","経常利益":"8,054百万円","当期利益":"2,015百万円","EPS（一株当たり利益）":"87.16円","調整一株当たり利益":"87.08円","BPS（一株当たり純資産）":"3,964.81円","総資産":"186,508百万円","自己資本":"91,671百万円","資本金":"13,001百万円","有利子負債":"36,351百万円","自己資本比率":"49.2%","ROA（総資産利益率）":"1.13%","ROE（自己資本利益率）":"2.21%","総資産経常利益率":"4.50%","__v":0,"日付":"2015-04-04T06:49:38.613Z"},{"_id":"551f898231cae9239deb17bf","会社名":"(株)カワチ薬品【2664】","証券コード":"2664","決算期":"2013年3月期","会計方式":"日本方式","決算発表日":"2013年4月24日","決算月数":"12か月","売上高":"231,657百万円","営業利益":"8,212百万円","経常利益":"8,990百万円","当期利益":"2,066百万円","EPS（一株当たり利益）":"88.01円","調整一株当たり利益":"87.99円","BPS（一株当たり純資産）":"3,918.51円","総資産":"171,291百万円","自己資本":"90,557百万円","資本金":"13,001百万円","有利子負債":"31,239百万円","自己資本比率":"52.9%","ROA（総資産利益率）":"1.21%","ROE（自己資本利益率）":"2.28%","総資産経常利益率":"5.27%","__v":0,"日付":"2015-04-04T06:49:38.613Z"},{"_id":"551f898231cae9239deb17c0","会社名":"(株)カワチ薬品【2664】","証券コード":"2664","決算期":"2012年3月期","会計方式":"日本方式","決算発表日":"2012年4月26日","決算月数":"12か月","売上高":"222,322百万円","営業利益":"10,041百万円","経常利益":"10,579百万円","当期利益":"4,417百万円","EPS（一株当たり利益）":"185.22円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"3,819.31円","総資産":"170,106百万円","自己資本":"90,412百万円","資本金":"13,001百万円","有利子負債":"32,135百万円","自己資本比率":"53.2%","ROA（総資産利益率）":"2.62%","ROE（自己資本利益率）":"4.96%","総資産経常利益率":"6.27%","__v":0,"日付":"2015-04-04T06:49:38.614Z"}]